SCNIScinai Immunotherapeutics Ltd. · NASDAQ · $304.4K mkt cap
Assessed Oct 8, 2026 · Float drift
Is the float you're seeing correct?
1.35M
Actual float

Started from the F-1 cover count of 1,353,228 ADS as of 2026-09-23 and subtracted the 3,503 affiliate ADS implied by the F-1's non-affiliate count.

Understated 95%
690.7K
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 1.35M shares.

Dilution risk7/10HIGH
CONFIDENCE: HIGH

The float your screener shows is understated 95%: 690.7K reported, 1.35M actual. 1 floorless convertible note and 3 reverse splits can add another 295% of the float.

  • ELOC draws and remaining capacity. The F-1 registers 2,706,450 ADS for Yorkville to resell, which is 200% of the 1,349,725 ADS float, from a SEPA with about $13.9M left.

  • Rapid share count growth. ADS outstanding rose from about 346,822 (2025-12-31, ratio-adjusted) to 570,022 (2026-06-30) to 1,353,228 (2026-09-23), up 290% in 9 months.

  • Recently registered shares not in data-service float. 473,275 SEPA ADS and 309,931 PFW-exercise ADS issued after June 30 are free-trading but missing from the Insight Sentry float (69,071) and outstanding count (570,022).

From today's float to the ceiling

shares
1.35M
Actual float
tradeable today
+49.3K can sell now
1.40M
Effective supply
float plus what sells on notice
+3.90M if floors are cut and warrants exercise
5.30M
Fully diluted
ceiling

Ceiling computed from the itemised overhang.

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
1.35M
Can sell now
Warrants in the money, at or near a zero strike
Exercisable at or below the current tape.
+49.3K
Effective supply
1.40M
Converts only if floors are cut
Convertible notes
At the stated conversion prices; a cut to those prices raises the count.
+2.71M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+36.4K
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+1.15M
Options and RSUs
Employee equity; vests and settles over time.
+12.2K
Fully diluted
5.30M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

Engine fully-diluted count (2.63M) is below the itemised overhang; ceiling computed from the rows.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$304.4K
Shares outstanding
570.0K
Reported float
690.7K
Avg volume
108.3K
Reverse splits
3 · latest 1-for-10 · Aug 21, 2026
Going concern
Yes · 0 quarters runway
Quarterly burn
—

Market data as of Oct 29, 2026

Key dates

  • Jan 4, 2027 · Expiry of the December 2023 inducement warrants (29,200 at $65) and agent warrants (876 at $81.25)
  • Apr 27, 2028 · Series A warrants (520,833 at $4.80) expire
  • Apr 27, 2031 · Series B and inducement warrants (592,737 at $5.50) expire